HK-listed YiChang HEC rises most in 3 months on robust sales outlook

Yichang Hec Changjiang Pharmaceutical Co

25/06/2021 04:45

** Shares of YiChang HEC ChangJiang Pharmaceutical Co Ltd
 1558.HK  rise as much as 10.9% to HK$7.94, the biggest intraday
percentage gain since March 22
    ** Stock hits its highest since April 30; among the 30
biggest percentage gainers on the Hong Kong bourse
    ** Company based in central province of Hubei says its newly
acquired aripiprazole and rivaroxaban tablets won bid for
centralised procurement, and sales volumes are set to increase
significantly  urn:newsml:reuters.com:*:nFWN2O50WM
    ** Says improved income structure will have a positive
impact on future operating performance
    ** The Hong Kong Hang Seng Commerce & Industry Index  .HSNC 
rises 1.5%
    ** The Hang Seng China Enterprises Index  .HSCE  climbs 1.4%
 and the benchmark index  .HSI  gains 1.1%
    ** By last close, the stock had fallen 18.9% this year

 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))